Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium falciparum | 24 | 2023 | 1732 | 1.810 |
Why?
|
| Antimalarials | 16 | 2023 | 905 | 1.450 |
Why?
|
| Drug Resistance | 13 | 2020 | 1609 | 1.000 |
Why?
|
| Malaria, Falciparum | 10 | 2023 | 1077 | 0.980 |
Why?
|
| Protozoan Proteins | 9 | 2020 | 827 | 0.960 |
Why?
|
| Plasmodium berghei | 4 | 2017 | 168 | 0.570 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2018 | 311 | 0.560 |
Why?
|
| Malaria | 6 | 2022 | 1239 | 0.500 |
Why?
|
| Atovaquone | 2 | 2022 | 58 | 0.500 |
Why?
|
| Gene Dosage | 1 | 2018 | 1252 | 0.450 |
Why?
|
| Drug Resistance, Multiple | 2 | 2018 | 252 | 0.450 |
Why?
|
| Quinolines | 1 | 2018 | 732 | 0.440 |
Why?
|
| Artemisinins | 4 | 2020 | 221 | 0.430 |
Why?
|
| Genetic Loci | 2 | 2013 | 2575 | 0.420 |
Why?
|
| Malaria, Cerebral | 1 | 2013 | 135 | 0.420 |
Why?
|
| Genome, Protozoan | 5 | 2018 | 142 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 535 | 0.400 |
Why?
|
| Host-Parasite Interactions | 1 | 2013 | 295 | 0.380 |
Why?
|
| Anopheles | 2 | 2022 | 197 | 0.340 |
Why?
|
| PPAR gamma | 1 | 2010 | 493 | 0.290 |
Why?
|
| Antigens | 1 | 2013 | 1466 | 0.290 |
Why?
|
| Amino Acyl-tRNA Synthetases | 2 | 2019 | 93 | 0.280 |
Why?
|
| Plasmodium | 2 | 2022 | 250 | 0.250 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2016 | 107 | 0.240 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 1152 | 0.240 |
Why?
|
| Cytochromes b | 2 | 2013 | 36 | 0.210 |
Why?
|
| Genome | 1 | 2010 | 1808 | 0.200 |
Why?
|
| Ligases | 1 | 2023 | 333 | 0.200 |
Why?
|
| Cambodia | 2 | 2018 | 191 | 0.190 |
Why?
|
| DNA Copy Number Variations | 4 | 2018 | 1941 | 0.190 |
Why?
|
| Hemeproteins | 1 | 2019 | 62 | 0.180 |
Why?
|
| Mutation | 8 | 2023 | 29786 | 0.170 |
Why?
|
| Antigenic Variation | 2 | 2013 | 125 | 0.160 |
Why?
|
| 4-Butyrolactone | 1 | 2018 | 63 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2019 | 190 | 0.160 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 81 | 0.150 |
Why?
|
| Quinazolinones | 2 | 2019 | 221 | 0.150 |
Why?
|
| Proline | 1 | 2019 | 458 | 0.150 |
Why?
|
| Evolution, Molecular | 2 | 2018 | 1940 | 0.140 |
Why?
|
| Erythrocytes | 5 | 2019 | 2455 | 0.140 |
Why?
|
| Microscopy | 1 | 2019 | 903 | 0.120 |
Why?
|
| Acrylamides | 1 | 2016 | 255 | 0.120 |
Why?
|
| Piperazines | 2 | 2016 | 2488 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2018 | 1726 | 0.110 |
Why?
|
| Diketopiperazines | 1 | 2012 | 20 | 0.110 |
Why?
|
| Poliovirus | 1 | 2012 | 109 | 0.100 |
Why?
|
| Decoquinate | 1 | 2011 | 3 | 0.100 |
Why?
|
| Isoleucine-tRNA Ligase | 1 | 2011 | 3 | 0.100 |
Why?
|
| Basophils | 1 | 2013 | 389 | 0.100 |
Why?
|
| Isoleucine | 1 | 2011 | 112 | 0.100 |
Why?
|
| Piperidines | 2 | 2019 | 1602 | 0.100 |
Why?
|
| Clindamycin | 1 | 2010 | 139 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 151 | 0.090 |
Why?
|
| Chromosomal Instability | 1 | 2010 | 184 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2013 | 10252 | 0.080 |
Why?
|
| Quinazolines | 1 | 2015 | 1356 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5882 | 0.080 |
Why?
|
| Mitosis | 1 | 2013 | 1208 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1827 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2008 | 197 | 0.070 |
Why?
|
| Drug Discovery | 2 | 2011 | 1058 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3798 | 0.070 |
Why?
|
| Imidazoles | 1 | 2011 | 1206 | 0.060 |
Why?
|
| DNA, Protozoan | 2 | 2016 | 237 | 0.060 |
Why?
|
| Molecular Structure | 3 | 2015 | 1899 | 0.060 |
Why?
|
| Haplotypes | 1 | 2010 | 2779 | 0.060 |
Why?
|
| Animals | 12 | 2022 | 168757 | 0.060 |
Why?
|
| Structure-Activity Relationship | 3 | 2015 | 3129 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 1782 | 0.060 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2012 | 83 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 4740 | 0.050 |
Why?
|
| Mice | 6 | 2017 | 81183 | 0.050 |
Why?
|
| Burkina Faso | 1 | 2021 | 88 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 1375 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 3597 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3920 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2012 | 2987 | 0.050 |
Why?
|
| Liver | 2 | 2015 | 7474 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4443 | 0.040 |
Why?
|
| Humans | 14 | 2023 | 744343 | 0.040 |
Why?
|
| Optical Phenomena | 1 | 2019 | 107 | 0.040 |
Why?
|
| Crystallization | 1 | 2019 | 524 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18029 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2015 | 5456 | 0.040 |
Why?
|
| Genomics | 1 | 2014 | 5720 | 0.040 |
Why?
|
| Genes, Protozoan | 1 | 2018 | 163 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2019 | 964 | 0.040 |
Why?
|
| Directed Molecular Evolution | 1 | 2018 | 160 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 10943 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 15519 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2018 | 435 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 298 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2018 | 914 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2016 | 560 | 0.030 |
Why?
|
| Reproduction | 1 | 2017 | 668 | 0.030 |
Why?
|
| Phenotype | 1 | 2010 | 16365 | 0.030 |
Why?
|
| Plasmodium yoelii | 1 | 2011 | 39 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 1792 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 1 | 2011 | 52 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2012 | 624 | 0.030 |
Why?
|
| Sporozoites | 1 | 2011 | 82 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2012 | 563 | 0.020 |
Why?
|
| Telomere | 2 | 2010 | 910 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7880 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 352 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Mupirocin | 1 | 2011 | 56 | 0.020 |
Why?
|
| Point Mutation | 1 | 2016 | 1623 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 18111 | 0.020 |
Why?
|
| Drug Design | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2183 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1484 | 0.020 |
Why?
|
| Fosfomycin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7722 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2008 | 803 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
| Peru | 1 | 2010 | 881 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2429 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2008 | 409 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 2011 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 1877 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6933 | 0.020 |
Why?
|
| Female | 5 | 2022 | 380194 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2011 | 720 | 0.020 |
Why?
|
| Base Sequence | 2 | 2010 | 12797 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9648 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 12072 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2011 | 1534 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 1063 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2010 | 3588 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2699 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.010 |
Why?
|
| Pedigree | 1 | 2010 | 4644 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6386 | 0.010 |
Why?
|
| Antigens, Protozoan | 1 | 2003 | 322 | 0.010 |
Why?
|
| Chromosomes | 1 | 2003 | 596 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.010 |
Why?
|
| Male | 2 | 2013 | 350118 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2018 | 12208 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 12951 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23403 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 16689 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9583 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7181 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 5867 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 29144 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 35136 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 214055 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_